Crossmark

A diabetes mellitus guideline gone wrong — the 2017 ACP update

Crossref DOI link: https://doi.org/10.1038/nrendo.2017.9

Published Online: 2017-02-03

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Home, Philip
License Information

Text and Data Mining valid from 2017-02-03
More Information

Article History

First Online: 3 February 2017

Competing interests

: The author or institutions with which he is associated have received funding for advisory, lecturing or research activities from Antriabio, AstraZeneca, Biocon, Eli Lilly, GlaxoSmithKline, Hanmi, Janssen, Merck (MSD), Novo Nordisk and Sanofi.